WHO grants EUA to AstraZeneca’s COVID-19 vaccine, shares soar by 6%
Category: #headlines  By Pranali Mehta  Date: 2021-02-17
  • share
  • Twitter
  • Facebook
  • LinkedIn
WHO grants EUA to AstraZeneca’s COVID-19 vaccine, shares soar by 6%
  • AstraZeneca COVID-19 vaccine has received approval in over 50 countries.
  • AstraZeneca vaccine is the second to be issued by the UN health agency, with Pfizer-BioNTech being the first.

Shares of AstraZeneca plc soared by 6% after the World Health Organization (WHO) reportedly granted a EUA (emergency use authorization) to its COVID-19 vaccine. This move could enable partners of the UN agency to ship millions of doses to economies as part of its global initiative to control the ongoing Coronavirus pandemic.

WHO stated that it would clear the British-Swedish multinational pharmaceutical company vaccines which are being developed by South Korea’s AstraZeneca-SKBio and the Serum Institute of India.

WHO’s declaration is expected to prompt the distribution of hundreds of millions of doses to economies that have joined the UN-backed COVAX initiative aimed at providing vaccines to the most vulnerable people in the world.

It is worth noting that the AstraZeneca vaccine has already been approved in over 50 countries, including Mexico, Argentina, India, and Britain. It is an inexpensive and simple dose to manage as compared to the Pfizer-BioNTech vaccine, which requires deep-cold storage, which is not common in many developing nations, sources claimed.

The use of the AstraZeneca COVID-19 vaccine was recommended by WHO experts, especially for people over the age of 18 years as well as in countries that have found COVID-19 variants.

Sources confirmed that post this development, the shares of the India unit of AstraZeneca Pharma increased by 9.7% to reach a high of USD 54.70 (Rs 3,985) on BSE (Bombay Stock Exchange).

After the Pfizer-BioNTech vaccine was approved in December by the WHO, the AstraZeneca vaccine is just the second approval given by the UN Health Agency.

Meanwhile, Australia has recently approved AstraZeneca’s COVID-19 vaccine and has requested around 53.8 million doses.

Source Credit –

https://economictimes.indiatimes.com/markets/stocks/news/astrazeneca-pharma-surges-10-as-who-okays-covid-vaccine-for-emergency-use/articleshow/80963175.cms

 

 

  • share
  • Twitter
  • Facebook
  • LinkedIn

About Author

Pranali Mehta

Pranali Mehta    

Pranali Mehta boasts of over three years of experience as a content writer. Having completed her graduation in chemical engineering, she worked as safety & environment associate in a chemical company for a year. Harnessing her passion for writing however, Pranali deci...

Read More >>

More News By Pranali Mehta

Indian fintech startup Clear secures USD 75 million in Series C funding
Indian fintech startup Clear secures USD 75 million in Series C funding
By Pranali Mehta

Clear (earlier known as ClearTax) has reportedly secured USD 75 million in a Series C funding round, which was led by Kora Capital. The latest funding round also saw participation from global fintech giant Stripe, Think Investments, Alua Capital, and...

CredAble bags USD 30 Mn Series B funding to expand product portfolio
CredAble bags USD 30 Mn Series B funding to expand product portfolio
By Pranali Mehta

Financing company CredAble recently raised USD 30 million in Series B funding to further develop its platform for providing working capital solutions especially for small businesses and developing innovative debt capital products for corporates and f...

FourKites launches new AI-based Dynamic ETA® for Ocean Shipping
FourKites launches new AI-based Dynamic ETA® for Ocean Shipping
By Pranali Mehta

FourKites, one of the world's leading real-time supply chain prominence platforms, has introduced an innovative industry-first AI-powered Dynamic ETA® for Ocean, as part of its Dynamic OceanSM contribution. As per sources, the new addition o...